WebApr 10, 2024 · The latest price target for GreenLight Biosciences ( NASDAQ: GRNA) was reported by Canaccord Genuity on Thursday, December 8, 2024. The analyst firm set a price target for 4.00 expecting GRNA... WebApr 6, 2024 · GreenLight Biosciences is seeking a highly motivated and collaborative automation engineer to join the Plant Health High-Throughput team. The successful candidate will develop automation methods on Hamilton Star, support automated HTP production at the Medford site and work on data analysis and trends with JIRA.
GreenLight Biosciences Releases Inaugural Sustainability Report
WebAug 11, 2024 · GreenLight Biosciences, an RNA technology startup working on mRNA vaccines, is going public through a SPAC deal. Environmental Impact Acquisition ( ENVI ), a blank-check company with backing from Canaccord Genuity Group (CCORF), is buying the RNA tech company in a deal which values it at around $1.5 billion. WebJan 9, 2024 · GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day GO! 01.09.23 GreenLight Biosciences and EpiVax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines 03.09.23 biosource cultures and flavors
GreenLight Biosciences Releases Inaugural Sustainability Report
WebAug 10, 2024 · GreenLight Biosciences Inc. is combining with a special-purpose acquisition company to go public in a deal that values the RNA-technology firm at … WebFeb 2, 2024 · Environmental Impact originally announced its $1.2 billion deal with GreenLight last year on August 10. Massachusetts-based GreenLight is developing a … WebApr 12, 2024 · BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Report. biosource corp ironwood mi